Aug 08, 2024 6:30am EDT Veru Reaches Full Enrollment for Phase 2b QUALITY Clinical Study of Enobosarm for Obesity and Reports Fiscal 2024 Third Quarter Financial Results
Jun 24, 2024 8:30am EDT Veru Announces Safety and Body Composition Data from Two Late-Breaker Presentations at the American Diabetes Association's 84th Scientific Sessions
Jun 17, 2024 4:45pm EDT Veru Reminds Shareholders to Vote in Advance of Tomorrow’s Deadline for 2024 Annual Meeting of Shareholders
Jun 10, 2024 8:30am EDT Veru to Present at the American Diabetes Association's 84th Scientific Sessions
